Industry news: Gardasil could prove to be Merck’s anti-Vioxx

October 07 2005

Merck’s experimental human papilloma virus (HPV) vaccine Gardasil, for prevention of cervical cancer, could prove a blockbuster many times over ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.